Full Press Release Details
National Stock Exchange of India Ltd. (Scrip Code: DRREDDY-EQ)
BSE Limited (Scrip Code: 500124)
New York Stock Exchange Inc. (Stock Code: RDY)
NSE IFSC Ltd (Stock Code: DRREDDY)
Further to our intimation dated June 7, 2024,
on the inspection conducted by the United States Food & Drug Administration (USFDA) at our API manufacturing facility (CTO-6) in Srikakulam,
Andhra Pradesh, we wish to inform you that the Company has received the Establishment Inspection Report (EIR). The USFDA has classified
the inspection as Voluntary Action Indicated (VAI) and concluded that the inspection is "closed" under 21 CFR 20.64(d)(3).
This is for your information and record.
For Dr. Reddy's Laboratories Limited
Company Secretary, Compliance Officer and Head-CSR